Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
D000230:Adenocarcinoma / Q000276:immunology*; D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000912:Antibodies, Neoplasm / Q000302:isolation & purification; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001667:Binding, Competitive; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D007111:Immunity, Cellular; D007074:Immunoglobulin G / Q000378:metabolism*; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D007774:Lactation; D008214:Lymphocytes / Q000276:immunology*; D008321:Mammary Glands, Animal / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000276:immunology*; D011247:Pregnancy; D051381:Rats; D011916:Rats, Inbred F344; D013601:T-Lymphocytes / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D007074:Immunoglobulin G